Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Melopsittacus undulatus feather refers to biological preparations derived from the feathers of the common budgerigar (*Melopsittacus undulatus*). In clinical medicine, these extracts are primarily utilized as diagnostic allergens for identifying sensitivities in individuals suspected of having avian-related allergic conditions, such as bird fancier's lung (hypersensitivity pneumonitis), allergic rhinitis, or asthma. The extract contains specific proteins that act as antigens, which, when introduced via skin prick testing or used in in vitro IgE assays, can elicit an immune response in sensitized patients. Beyond its diagnostic use, it is also recognized in homeopathic medicine as a remedy prepared through serial dilution and succussion, where it is traditionally indicated for a variety of physical and behavioral symptoms based on the principle of "like cures like."
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on melopsittacus undulatus feather.